Bone mineral density in early-onset hypogonadism and the effect of hormonal replacement

Journal of Clinical Densitometry

Volumn 7, Issue 3, 2004, Pages 334-340

  Da Costa, Jocely Vieira ^a   Pereira Lima, Julia Fernanda Semmelmann ^a   Da Costa Oliveira, Miriam ^a,b  

^a Fund Faculdade Fed Cie Medicas P   (Brazil)

^b NONE   (Brazil)

Author keywords

Bone mass; Bone mineral density; GH deficiency; Hormonal replacement; Hypogonadism

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL VALERATE; ETHINYLESTRADIOL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LUMBAR SPINE; MALE; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; STANDARD; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

EID: 4444381555     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:7:3:334     Document Type: Article

References (59)

1. Willing M, Sowers M, Aron D, et al. 1998 Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695-705.
2. Neer RM. 1995 Osteoporosis. In: Endocrinology, 3th ed. De Groot L, Besser M, Burger HG, et al. eds. Philadelphia; WB Saunders, 1228-1258.
3. Arizaka O, Arisaka M, Nakayama Y, Fujiwara S, Yabuta K. 1995 Effect of testosterone on bone density metabolism in adolescent. Metabolism 44:419-423.
4. Oliveira MC, Souza AC, Hoffmann KS, Pereira-Lima JFS, Wolff H. 1995 Resultados da densitometria óssea em pacientes com hipogonadismo. Arq Bras Endocrinol Metab 39:170-178.
5. Hergenroeder AC, Smith OB, Shypailo BS, Jones LA, Klish WJ, Ellis K. 1997 Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol 176:1017-1025.
6. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A. 1992 Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600-604.
7. Biberoglu K, Yildiz A, Kandemir O. 1993 Bone loss in young women with primary hypogonadism and prevention with calcitonin. Gynecol Obstet Invest 36:114-118.
8. Wang C, Eyre DR, Clark R, et al. 1996 Sublingual testosterone replacement improves muscle mass and strength, decrease bone resorption, and increases bone formation markers in hypogonadal men - a clinical resarch center study. J Clin Endocrinol Metab 81:3654-3662.
9. Lewin S, Gouveia CHA, Marone MMS, Wehba S, Malvestiti LF, Bianco AC. 1997 Densidade mineral óssea vertebral e femoral de 724 mulheres brancas brasileiras: influência da idade e do peso corporal. Rev Ass Med Brasil 43:127-136.
10. Faulkner RA, Bailey DA, Drinkwater DT, McKay HA, Arnold C, Wilkingson AA. 1996 Bone densitometry in Canadians 8-17 years of age. Calcif Tissue Int 59:344-351.
11. Brown DM, Jowsey J, Phil D, Bradford DS. 1974 Osteoporosis in ovarian dysgenesis. J Pediatr 84:816-820.
12. Genant HR, Cann CE, Ettinger B, Gordan GS. 1982 Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699-705.
13. Fabbri G, Petraglia F, Segre A, et al. 1991 Reduced spinal bone density in young women with amenorrhoea. Eur J Obstet Gynecol Reproduce Biol 41:117-122.
14. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM. 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618-1623.
15. Davies MC, Gulekli B, Jacobs HS. 1995 Osteoporosis in Turner's syndrome and the other forms of amenorrhoea. Clin Endocrinol 43:741-746.
16. Maugars YM, Berthelot JMM, Forestier R, et al. 1996 Follow-up of bone mineral density in 27 cases of anorexia nervosa. Eur J Endocrinol 135:591-597.
17. Takahashi Y, Minamitani K, Kobayashi Y, Minagawa M, Yashuda T, Niimi H. 1996 Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and hypogonadism. J Clin Endocrinol Metab 81:1248-1253.
18. Miller KK, Klibanski A. 1999 Amenorrheic bone loss. J Clin Endocrinol Metab 84:1775-1783.
19. Davies MC, Hall ML, Jacobs HS. 1990 Bone mineral loss in young women with amenorrhoea. Br Med J 301:790-793.
20. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. 1982 Skeletal demineralization in Turner's syndrome. Calcif Tissue Int 34:519-522.
21. Smith MA, Wilson J, Price WH. 1982 Bone demineralization in patient with Turner's syndrome. J Med Gen 19:100-103.
22. Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GB. 1991 Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J Clin Endocrinol Metab 73:355-359.
23. Sylvén L, Hagenfeldt K, Ringertz H. 1995 Bone mineral density in middle-age women with Turner's syndrome. Eur J Endocrinol 132:47-52.
24. Moore WT, Simon J, Taylor T. 1996 Diseases of Bone. In: Diagnostic Endocrinology, 2nd ed. Moore WT, Eastman RC, eds. St. Louis, MO: Mosby, 373-409.
25. Bhasin S. 1992 Androgen treatment of hypogonadal men. J Clin Endocrinol Metab 74:1221-1225.
26. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. 1986 Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 104:777-782.
27. Finkelstein JS, Klibanski A, Neer RM, et al. 1989 Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69:776-783.
28. Van Der Werff Ten Bosch JJ, Bot A. 1992 Some skeletal dimensions of males with isolated gonadotrophin deficiency. Neth J Med 41:259-263.
29. Diamond T, Nery L, Posen S. 1989 Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111:567-573.
30. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. 1998 Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol 48:59-65.
31. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G. 1995 Short-term of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 10:1488-1495.
32. Suzuki Y, Aikawa K, Oishi Y, et al. 1998 A clinical study of decreased bone density in the patients treated with long-term luteinizing hormone releasing hormone analogue (LHRH-a) - the risk of iatrogenic osteoporosis due to treatment of carcinoma of prostate. Nippon Hinyokika Gakkai Zasshi 89:961-966.
33. Di Stefano M, Jorizzo RA, Brusco G, et al. 1998 Bone mass and metabolism in Whipple's disease: the role of hypogonadism. Scand J Gastroenterol 33:1180-1185.
34. Smith DAS, Walker MS. 1977 Change in plasma steroids and bone density in Klinefelter's syndrome. Calcif Tissue Res 22:225-228.
35. Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BEC. 1992 Osteoporosis and Klinefelter syndrome. Clin Endocrinol 36:113-118.
36. Luisetto G, Mastrogiacomo I, Bonanni G, et al. 1995 Bone mass and mineral metabolism in Klinefelter's syndrome. Osteoporosis Int 5:455-461.
37. De Rosa M, Paesano L, Nuzzo, et al. 2001 Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment. J Endocrinol Invest 24:246-252.
38. Kaufman JM, Taelman P, Vereulen A, Vandeweghe M. 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118-123.
39. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes S, Adams J, Shalet S. 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348.
40. Holmes SJ, Shalet SM. 1996 Role of groth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res 45:86-93.
41. Degerblad M, Elgindy N, Hall K, Sjöberg H-E, Thorén M. 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 126:387-393.
42. Lindsay R, MacLean A, Kraszewski A, Hart DM, Clark AC, Garwood J. 1978 Bone response to termination of oestrogen treatment. Lancet 78:1325-1327.
43. Holzer G, Metka M, Heymanek G, Knogler W, Huber J. 1992 Bone density before and after the therapy of young women with hypergonadotropic amenorrhea. Dtsch Med Wochensch 117:283-286.
44. Hergenroeder AC, Smith OB, Shypailo BS, Jones LA, Klish WJ, Ellis K. 1997 Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol 176:1017-1025.
45. Naeraa RW, Brixen K, Hansen RM, et al. 1991 Skeletal size and bone mineral content in Turner's syndrome: relation to kariotype, estrogen treatment, physical fitness, and bone turnover. Calcif Tissue Int 49:77-83.
46. Rubin K. 1998 Turner syndrome and osteoporosis: mechanism and prognosis. Pediatrics 102:481-482.
47. Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV. 1978 Effect of testosterone therapy on bone formation in a osteoporotic hypogonadal male. Calcif Tissue Res 26:103-106.
48. Katznelson L. 1998 Therapeutic role of androgens in the treatment of oteoporosis in men. Ballières Clin Endocrinol Metab 12:453-470.
49. Devogelaer JP, De Cooman S, Nagant DC. 192 Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. Maturitas 15:17-23.
50. Isaia G, Mussetta M, Pecchio F, Sciolla A, Di Stefano M, Molinatti GM. 1992 Effect of testosterone on bone in hipogonadal males. Maturitas 15:47-51.
51. Bertellonni S, Barocelli GI, Battini R, Perri G, Saggese G. 1995 Short-term of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 10:1488-1495.
52. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. 1996 Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358-4365.
53. Behre HM, Eckardstein S, Kliesch S, Nieschag E. 1999 Long-term substitution therapy of gonadal men with transcrotal testosterone over 7-10 years. Clin Endocrinol 50:629-635.
54. Vanderschueren D, Bouillon R. 1995 Androgens and bone. Calcif Tissue Int 56:341-346.
55. Medras M, Jankowska EA, Rogucka E. 2002 Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism. Andrologia 33:47-52.
56. Van den Bergh JP, Hermus AR, Spruyt AI, Sweep CG, Corstens FH, Smals AG. 2001 Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution. Osteoporos Int 12:55-62.
57. Wong FHW, Pun KK, Wang C. 1993 Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement. Osteoporos Int 3:3-7.
58. Behre HM, Kliesch S, Link TM, Nieschlang E. 1997 Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82:2386-2390.
59. Seeman E. 1997 Osteoporosis in men. Baillières Clin Rheumatol 11:613-629.